• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Synovus Financial Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    4/16/25 4:40:34 PM ET
    $SNV
    Major Banks
    Finance
    Get the next $SNV alert in real time by email
    syn-20250416
    0000018349false00000183492025-04-162025-04-160000018349us-gaap:CommonStockMember2025-04-162025-04-160000018349us-gaap:SeriesDPreferredStockMember2025-04-162025-04-160000018349us-gaap:SeriesEPreferredStockMember2025-04-162025-04-16

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 8-K

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of
    the Securities Exchange Act of 1934

    April 16, 2025
    Date of Report
    (Date of Earliest Event Reported)

    Synovus Financial Corp.
    (Exact Name of Registrant as Specified in its Charter)
    Georgia1-1031258-1134883
    (State of Incorporation)(Commission File Number)(IRS Employer Identification No.)

    33 W. 14th Street, Columbus, Georgia 31901
    (Address of principal executive offices) (Zip Code)

    (706) 641-6500
    (Registrant’s telephone number, including area code)

    ________________________________________________
    (Former name or former address, if changed since last report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

        ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

        ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

        ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

        ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, $1.00 Par Value
    SNV
    New York Stock Exchange
    Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series D
    SNV-PrD
    New York Stock Exchange
    Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series E
    SNV-PrE
    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 2.02Results of Operations and Financial Condition
    On April 16, 2025, Synovus Financial Corp. (the "Company") issued a press release announcing the Company’s financial results for the three month period ended March 31, 2025.
    Pursuant to General Instruction F to Current Report on Form 8-K, the press release is attached to this Current Report as Exhibit 99.1 and only those portions of the press release related to the historical results of operations of the Company for the three month period ended March 31, 2025 are incorporated into this Item 2.02 by reference. The information contained in this Item 2.02, including the information set forth in the press release filed as Exhibit 99.1 to, and incorporated in, this Current Report is being "furnished" and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in Exhibit 99.1 furnished pursuant to this Item 2.02 shall not be incorporated by reference into any registration statement or other documents pursuant to the Securities Act of 1933, as amended (the "Securities Act"), or into any filing or other document pursuant to the Exchange Act except as otherwise expressly stated in any such filing.
    Item 7.01Regulation FD Disclosure
    On April 16, 2025, the Company made available the slide presentation ("Slide Presentation") prepared for use with the press release. The investor call and webcast will be held at 8:30 a.m., ET, on April 17, 2025.
    The information contained in this Item 7.01 of this Current Report, including the information set forth in the Slide Presentation filed as Exhibit 99.2 to, and incorporated in, this Current Report, is being "furnished" and shall not be deemed "filed" for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section. The information in Exhibit 99.2 furnished pursuant to this Item 7.01 shall not be incorporated by reference into any registration statement or other documents pursuant to the Securities Act or into any filing or other document pursuant to the Exchange Act except as otherwise expressly stated in any such filing.
    Item 9.01Financial Statements and Exhibits
    (d)Exhibits
    Exhibit No.Description
    99.1
    Synovus press release dated April 16, 2025
    99.2
    Slide presentation prepared for use with the press release




    Signature

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, Synovus has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    SYNOVUS FINANCIAL CORP.
    Date: April 16, 2025
    By: /s/ Allan E. Kamensky
    Name: Allan E. Kamensky
    Title: Executive Vice President and General Counsel
             


    Get the next $SNV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SNV

    DatePrice TargetRatingAnalyst
    5/21/2025$55.00Hold
    Jefferies
    4/2/2025Outperform → Mkt Perform
    Raymond James
    12/17/2024Buy
    UBS
    12/9/2024$64.00Buy
    Deutsche Bank
    10/10/2024$53.00Buy
    Citigroup
    10/1/2024$48.00 → $46.00Overweight → Equal Weight
    Wells Fargo
    9/17/2024$49.00Mkt Perform → Outperform
    Raymond James
    6/24/2024$39.00 → $46.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $SNV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Jefferies initiated coverage on Synovus with a new price target

      Jefferies initiated coverage of Synovus with a rating of Hold and set a new price target of $55.00

      5/21/25 9:01:11 AM ET
      $SNV
      Major Banks
      Finance
    • Synovus downgraded by Raymond James

      Raymond James downgraded Synovus from Outperform to Mkt Perform

      4/2/25 8:48:19 AM ET
      $SNV
      Major Banks
      Finance
    • UBS resumed coverage on Synovus

      UBS resumed coverage of Synovus with a rating of Buy

      12/17/24 9:37:44 AM ET
      $SNV
      Major Banks
      Finance